CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.370
-0.025 (-0.74%)
At close: May 14, 2025, 4:00 PM
3.420
+0.050 (1.48%)
After-hours: May 14, 2025, 4:23 PM EDT
CureVac Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for CureVac stock ranges from a low of $12 to a high of $16. The average analyst price target of $14 forecasts a 315.43% increase in the stock price over the next year.
Price Target: $14.00 (+315.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CureVac stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +256.08% | Apr 30, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +374.78% | Feb 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +374.78% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +374.78% | Aug 16, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +434.12% | Jul 3, 2024 |
Financial Forecast
Revenue This Year
70.03M
from 535.18M
Decreased by -86.91%
Revenue Next Year
96.50M
from 70.03M
Increased by 37.79%
EPS This Year
-0.53
from 0.72
EPS Next Year
-0.41
from -0.53
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 133.6M | 166.5M | 211.2M | ||
| Avg | 70.0M | 96.5M | 143.5M | ||
| Low | n/a | 60.0M | 78.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -75.0% | 137.7% | 118.9% | ||
| Avg | -86.9% | 37.8% | 48.7% | ||
| Low | - | -14.4% | -18.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.12 | -0.13 | 0.36 |
| Avg | -0.53 | -0.41 | -0.01 |
| Low | -0.79 | -0.69 | -0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.